Old chemotherapy makes a comeback: dual alkylator therapy for pediatric high-grade glioma.
Division of Haematology/Oncology, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada (E.B., V.R.); eric.bouffet@sickkids.ca.
Eric
E
Bouffet
Division of Haematology/Oncology, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada (E.B., V.R.);
Vijay
V
Ramaswamy
D000477:Alkylating Agents; D001932:Brain Neoplasms; D002648:Child; D005910:Glioma; D006801:Humans
D000477:Alkylating Agents
Cancer Cell. 2012 Oct 16;22(4):425-37
23079654
Neuro Oncol. 2015 Oct;17 Suppl 4:iv1-iv62
26511214
Neuro Oncol. 2011 Mar;13(3):317-23
21339192
J Clin Oncol. 2009 Mar 10;27(8):1257-61
19188676
J Neurooncol. 1989 Jul;7(2):165-77
2550594
J Clin Oncol. 1995 Jan;13(1):112-23
7799011
J Clin Oncol. 2006 Sep 20;24(27):4412-7
16983109
Neuro Oncol. 2016 Jun 9;:null
27282398
Cancer Res. 1994 Jul 15;54(14 ):3793-9
8033099
J Clin Invest. 2012 Jan;122(1):253-66
22156195
N Engl J Med. 2005 Mar 10;352(10 ):987-96
15758009
Neuro Oncol. 2016 Oct;18(10):1442-50
27006176